Utility of the CPS+EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Utility of the CPS+EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy

Published:2016-01 Issue: Volume:53 Page:65-74
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Marmé Frederik,Lederer Bianca,Blohmer Jens-Uwe,Costa Serban Dan,Denkert Carsten,Eidtmann Holger,Gerber Bernd,Hanusch Claus,Hilfrich Jörn,Huober Jens,Jackisch Christian,Kümmel Sherko,Loibl Sibylle,Paepke Stefan,Untch Michael,von Minckwitz Gunter,Schneeweiss Andreas

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013;Goldhirsch;Ann Oncol: Off J Eur Soc Med Oncol/ESMO,2013

2. Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer;Kaufmann;Ann Surg Oncol,2012

3. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18;Fisher;J Clin Oncol: Off J Am Soc Clin Oncol,1997

4. Response-guided neoadjuvant chemotherapy for breast cancer;von Minckwitz;J Clin Oncol,2013

5. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes;von Minckwitz;J Clin Oncol: Off J Am Soc Clin Oncol,2012

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study;The Breast;2024-08

2. Adjuvant treatment strategy evolution and risk stratification for hormone receptor-positive, human epidermal growth factor receptor-2 negative early breast cancer in China;The Oncologist;2024-05-23

3. Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy;European Journal of Cancer;2024-05

4. A Research Protocol for a Phase II Single-Arm Clinical Trial Assessing the Feasibility and Efficacy of Neoadjuvant Anastrozole in Patients With Luminal Breast Cancer and Low Proliferative Index: The ANNE Trial;Cancer Control;2024-01

5. Postneoadjuvante Therapie des Mammakarzinoms;Die Onkologie;2023-11-10